Category: Latest News
-
Novo Nordisk Shares Dip Amid Spanish Probe into Obesity Campaign
Novo Nordisk A/S (NYSE:NVO) saw its stock decline 2.1% in premarket trading after Spain’s health ministry initiated an inquiry into the company’s obesity awareness campaign, which may have violated the country’s strict prescription drug advertising regulations. The Danish pharmaceutical leader is facing scrutiny following concerns that the campaign’s website, removed on June 24, might have…
-
Paychex Reports Q4 Results In Line with Estimates, Stock Dips
Paychex Inc. (NASDAQ:PAYX) shares slipped 2.8% in premarket trading Wednesday after the HR services provider posted fourth-quarter financial results that met analyst expectations on both revenue and earnings. The company reported adjusted diluted earnings per share (EPS) of $1.19 for the quarter, exactly matching consensus forecasts. Revenue came in at $1.43 billion, representing a solid…
-
ECARX Shares Surge Following Collaboration with Robotic Lawn Mower Innovator
ECARX Holdings Inc. (NASDAQ:ECX) stock jumped 9% in pre-market trading Wednesday after the mobility technology company revealed a new partnership to integrate its lidar systems into robotic lawn mowers. The deal with a prominent yet unnamed global developer of robotic lawn mowers signals ECARX’s strategic move to broaden its reach beyond automotive intelligence into the…
-
AgEagle Aerial Systems Shares Climb on Increased Drone Sales in South Korea
AgEagle Aerial Systems Inc. (NYSE:UAVS) saw its stock rise by 2% following the announcement of two additional eBee X drone sales in South Korea. This sale pushes the total number of AgEagle’s eBee drones operating in the country to over 100 units. The eBee X, a leading fixed-wing drone built for precise geospatial data gathering,…
-
Contineum Therapeutics Shares Drop After Delay in Trial Data Release
Contineum Therapeutics Inc (NASDAQ:CTNM) experienced an 8.4% decline in its stock price following the announcement of a delay in releasing topline results from its Phase 1b study of PIPE-791. The biopharmaceutical company, currently in the clinical stage, completed enrolling both healthy volunteers and patients with progressive multiple sclerosis (PrMS) for the trial. However, it now…
-
Bumble Shares Jump After Company Announces 30% Staff Reduction
Bumble (NASDAQ:BMBL) shares climbed 13% following the company’s announcement of plans to cut approximately 240 jobs worldwide, amounting to about 30% of its workforce. In a regulatory filing, Bumble revealed that its Board of Directors approved the layoffs on June 23, 2025, aiming to “realign its operating structure to better focus on strategic priorities.” The…
-
Tesla’s European Sales Decline Amid Rising Competition from Chinese EV Brands
Tesla (NASDAQ:TSLA) experienced a significant 27.9% drop in new vehicle sales across Europe in May compared to the previous year, even as fully electric vehicle sales surged 27.2% in the region. The American electric carmaker’s market share in Europe shrank to 1.2% in May from 1.8% a year earlier, marking the fifth straight month of…
-
Allot Shares Drop After Pricing Public Offering at $8 per Share
Shares of Allot Ltd. (NASDAQ:ALLT) declined by 13% following the announcement of its underwritten public offering priced at $8.00 per share, marking a steep discount compared to the previous close of $9.61. The company, which specializes in network intelligence and security solutions, is offering 5 million ordinary shares, with an additional option for underwriters to…
-
General Mills Predicts Decline in Annual Earnings Amid Difficult Market Conditions
General Mills (NYSE: GIS) has issued a cautionary forecast for its current fiscal year, highlighting weak category sales growth and a decline in income as the company navigates challenges from tariff-related cost pressures. The packaged foods leader, known for brands like Cheerios and Chex, is feeling the impact of consumers tightening their budgets amid ongoing…
-
AST SpaceMobile Shares Drop Following $225 Million Convertible Note Buyback
AST SpaceMobile (NASDAQ:ASTS) shares declined by 7.75% after the company revealed plans to repurchase $225 million of its convertible notes due 2032 and to raise funds through a registered direct offering of common stock. The company will buy back $225 million of its 4.25% convertible notes maturing in 2032 via private deals with select noteholders.…